Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Immunoglobulin gamma 1 (IgG1) Fc region is the C-terminal portion of the IgG1 antibody, consisting of the CH2 and CH3 constant domains (Vidarsson G, et al. Front Immunol. 2014). It serves as the primary interface between the adaptive immune system and innate effector mechanisms by binding to Fc gamma receptors (FcγRs) on leukocytes (Wang TT, et al. Annu Rev Immunol. 2019). This interaction facilitates antibody-dependent cellular cytotoxicity (ADCC) and phagocytosis, which are essential for clearing pathogens and tumor cells. Furthermore, the Fc region binds to the neonatal Fc receptor (FcRn) in a pH-dependent manner, a process that protects the antibody from lysosomal degradation and extends its half-life in circulation to approximately three weeks (Roopenian DC, et al. Nat Rev Immunol. 2007). In biotechnology, the IgG1 Fc region is frequently engineered to modulate these effector functions or to create Fc-fusion proteins that benefit from its stability. In the context of autoimmune diseases, the IgG1 Fc-FcRn pathway is targeted by novel therapeutics like efgartigimod to accelerate the clearance of pathogenic autoantibodies (Gable K, et al. Neurotherapeutics. 2022).
Modulation of Fc-mediated effector functions and competitive inhibition of the neonatal Fc receptor (FcRn) to regulate IgG1 serum concentrations.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Immunoglobulin gamma 1 Fc region (IgG1 Fc) (IgG1 Fc).